Cooper Companies' Unit Completes Acquisition of Leisegang Women's Healthcare Products.Business Editors and Health/Medical Writers IRVINE, Calif.--(BW HealthWire)--Jan. 31, 2000 The Cooper Companies, Inc. (NYSE/PCX: COO) Monday announced that its CooperSurgical (CSI CSI Crime Scene Investigator CSI CompuServe, Inc. CSI Commodity Systems, Inc. CSI Commodity Systems Inc. (Boca Raton, FL) CSI Crime Scene Investigation (CBS TV show) CSI Christian Schools International ) women's healthcare unit has completed the purchase of a group of women's healthcare products from Leisegang Medical, Inc. for approximately $10.5 million in cash. The products currently generate annual revenue in excess of $11 million. Cooper expects the transaction to be accretive to fiscal 2000 earnings. Leisegang is a subsidiary of NetOptix Corporation (Nasdaq: OPTX). Leisegang is a well-known and highly regarded women's healthcare company. It markets diagnostic and surgical instruments A surgical instrument is a specially designed tool or device for performing specific actions of carrying out desired effects during a surgery or operation, such as modifying biological tissue, or to provide access or viewing it. including colposcopes, instruments to perform loop electrosurgical excision procedures Loop electrosurgical excision procedure (LEEP) Cone biopsy performed with a wire that is heated by electrical current. Mentioned in: Cervical Cancer , hand held gynecological gynecological /gy·ne·co·log·i·cal/ (-kah-loj´i-k'l) gynecologic. instruments, disposable specula spec·u·la n. A plural of speculum. and cryosurgical systems. Many of its products are disposable, including its Sani-Spec(R) line of disposable plastic specula, its largest product group. The acquisition will expand CSI's global presence, as it plans to market its line of gynecological products through Leisegang's German subsidiary. In December 1999, CSI announced that it had completed the acquisition of a line of women's healthcare products from BEI Bei (pā, bā), river, c.200 mi (320 km) long, formed by the union of two headstreams in the Nanling Mts., N Guangdong prov., S China. It flows S into the Xi River, E of Guangzhou, to form the Pearl River delta. Medical Systems. CSI's annual revenue will exceed $50 million in calendar year 2000 with the addition of these new product lines. The Cooper Companies, Inc. and its subsidiaries develop, manufacture and market specialty healthcare products. CooperSurgical, Inc., with headquarters in Shelton, Conn., markets diagnostic products, surgical instruments and accessories for the gynecological market. CooperVision, Inc., with headquarters in Irvine, with manufacturing facilities in Huntington Beach Huntington Beach, city (1990 pop. 181,519), Orange co., S Calif., on the Pacific coast, across from Santa Catalina Island, in an oil-producing area; inc. 1909. It manufactures aerospace vehicles, aircraft parts, optical instruments, and heat transfer equipment. , Calif., Rochester, N.Y., Toronto, Canada and Hamble, England, markets a broad range of contact lenses contact lenses contact npl → verres mpl de contact contact lenses contact npl → Kontaktlinsen pl contact lenses npl for the vision care market. Corporate offices are located in Irvine and Pleasanton, Calif. A toll free interactive telephone system at 800/334-1986 provides stock quotes, recent news releases and financial data. Cooper's web address is www.coopercos.com. Forward-Looking Statements This news release contains &uot;forward-looking statements&uot; as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. To identify forward-looking statements, look for words like &uot;believes,&uot; &uot;expects,&uot; &uot;may,&uot; &uot;will,&uot; &uot;should,&uot; &uot;seeks,&uot; &uot;approximately,&uot; &uot;intends,&uot; &uot;plans,&uot; &uot;estimates&uot; or &uot;anticipates&uot; and similar words or phrases. Discussions of strategy, plans or intentions often contain forward-looking statements. These, and all forward-looking statements, necessarily depend on assumptions, data or methods that may be incorrect or imprecise. Events, among others, that could cause actual results and future actions to differ materially from those described by or contemplated in the forward-looking statements include major changes in business conditions and the economy, loss of key senior management, major disruptions in the operations of Cooper's manufacturing facilities, new competitors or technologies, significant disruptions caused by third parties failing to address the year 2000 issue, or by problems with our year 2000 compliance program, the impact of an undetected virus on our computer system, acquisition integration costs, foreign currency exchange exposure, investments in research and development and other start-up projects, dilution to earnings per share from acquisitions or issuing stock, regulatory issues, significant environmental cleanup costs above those already accrued, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. costs, costs of business divestitures, and other factors described in Cooper's Securities and Exchange Commission filings, including the &uot;Business&uot; section in our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended October 31, 1999. Cooper cautions investors not to rely unduly on forward-looking statements. They reflect our analysis only on their stated date or the date of this news release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion